[go: up one dir, main page]

WO2014083438A3 - Nitric oxide increasing nutritional supplements and methods - Google Patents

Nitric oxide increasing nutritional supplements and methods Download PDF

Info

Publication number
WO2014083438A3
WO2014083438A3 PCT/IB2013/003186 IB2013003186W WO2014083438A3 WO 2014083438 A3 WO2014083438 A3 WO 2014083438A3 IB 2013003186 W IB2013003186 W IB 2013003186W WO 2014083438 A3 WO2014083438 A3 WO 2014083438A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutritional supplements
methods
nitric oxide
oxide increasing
increasing nutritional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2013/003186
Other languages
French (fr)
Other versions
WO2014083438A2 (en
Inventor
Terence Fealey
Philip A. HARDY
Brazos G. MINSHEW
Michael Calvin WITHROW
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abattis Bioceuticals Corp
Original Assignee
Abattis Bioceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abattis Bioceuticals Corp filed Critical Abattis Bioceuticals Corp
Priority to CA2928777A priority Critical patent/CA2928777A1/en
Publication of WO2014083438A2 publication Critical patent/WO2014083438A2/en
Publication of WO2014083438A3 publication Critical patent/WO2014083438A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The inventive concepts disclosed herein relate to nutritional supplements and, more particularly, but not by way of limitation, to nitric oxide increasing nutritional supplements and methods.
PCT/IB2013/003186 2012-11-09 2013-11-08 Nitric oxide increasing nutritional supplements and methods Ceased WO2014083438A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2928777A CA2928777A1 (en) 2012-11-09 2013-11-08 Nitric oxide increasing nutritional supplements and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261724425P 2012-11-09 2012-11-09
US61/724,425 2012-11-09

Publications (2)

Publication Number Publication Date
WO2014083438A2 WO2014083438A2 (en) 2014-06-05
WO2014083438A3 true WO2014083438A3 (en) 2014-11-13

Family

ID=50828554

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/003186 Ceased WO2014083438A2 (en) 2012-11-09 2013-11-08 Nitric oxide increasing nutritional supplements and methods

Country Status (2)

Country Link
CA (1) CA2928777A1 (en)
WO (1) WO2014083438A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10342873B2 (en) 2016-05-06 2019-07-09 Physician's Seal, LLC Valerian composition and related methods
CN110200830B (en) * 2019-05-23 2021-08-03 广州科斯曼生物科技有限公司 Anti-inflammatory and allergy-relieving repair composition and preparation method and application thereof
US11389428B2 (en) 2011-01-28 2022-07-19 Société des Produits Nestlé S.A. Controlled-release melatonin compositions and related methods

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US11241406B2 (en) * 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels
WO2017155515A1 (en) * 2016-03-08 2017-09-14 MANSOUR, Mariam, Awadh Herbal sonicated e-nano e-liquid mix for zero-nicotine e-cigarette for improving smoker's health
GB2550913B (en) * 2016-05-28 2019-01-02 Rocco Tulino Rosario Specific product, obtained from a blending of oils and other active essences acquired by exclusive physical extraction from seeds and germs
WO2019004962A2 (en) * 2017-03-09 2019-01-03 Us Kahve Bi̇tki̇sel Yağ Üreti̇mi̇ İhracat İthalat San. Ve Ti̇c. Ltd. Şti̇. Mix of aromatic canola oil and pistachio terebinthus oil
CN106947726B (en) * 2017-05-25 2021-01-29 华中农业大学 High-density fermentation and cold air drying method for lactobacillus casei
KR20210046576A (en) * 2017-07-20 2021-04-28 친니 크리쉬난 라즈 쿠마르 How to improve nitric oxide levels in users
WO2019046660A1 (en) * 2017-08-30 2019-03-07 Shawn Talbott Nutritional supplements affecting gut-brain-axis balance and mental wellness
AU2019330972A1 (en) * 2018-08-28 2021-02-25 Ralco Nutrition, Inc. Feed compositions and feed additive compositions for aquaculture species
EP3955945A4 (en) * 2019-04-13 2023-01-11 Azista Industries Pvt Ltd Polyherbal transdermal patch for pain management and its process of preparation
WO2020231906A1 (en) * 2019-05-10 2020-11-19 Bgs Holdings Llc Sports and nutritional supplement formulations
US11529386B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting mood and focus in children
WO2021046459A1 (en) 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of nutritional supplementation affecting heart/brain axis
WO2021046450A1 (en) 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of supplementation affecting the endocannabinoid system
WO2021188295A1 (en) * 2020-03-17 2021-09-23 Epidarus Therapeutics, Llc Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
NL2025679B1 (en) * 2020-05-26 2021-12-13 Johanna Daams Brechtje Electrical stimulation for preventing or treating nitric oxide deficiency related conditions
CN111778296B (en) * 2020-07-14 2022-12-06 菏泽市食品药品检验检测研究院 Method for producing quercetin by immobilized enzyme catalysis
IT202000027897A1 (en) * 2020-11-20 2022-05-20 Aqma Italia S P A COMBINATION COMPOSITION FOR THE TREATMENT OF ERECTILE DYSFUNCTION
CN112956624A (en) * 2021-03-17 2021-06-15 吉林化工学院 Research on stability of corn stigma compound beverage
IT202100015446A1 (en) * 2021-06-14 2022-12-14 Nutras S R L Formulation based on Cranberry extract, Uva Ursi, and a third extract
US20230082235A1 (en) * 2021-09-15 2023-03-16 Christina Nadine Evans System and method for topical spray, salve, and tincture
WO2024173775A1 (en) * 2023-02-16 2024-08-22 Codex Labs Corporation Dietary supplement for managing stress-induced inflammatory skin disorders
WO2025181810A1 (en) * 2024-03-01 2025-09-04 Nlc Pharma Ltd Botanical antiviral composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOCH, E. ET AL.: "Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders - Preclinical and Clinical Studies.", PLANTA MED., vol. 77, 2011, pages 1123 - 1128 *
TANKANOW, R. ET AL.: "Interaction study between digoxin and a preparation of Hawthorn (Crataegus oxyacantha).", J CLIN PHARMACOL., vol. 43, no. 6, 2003, pages 637 - 642 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389428B2 (en) 2011-01-28 2022-07-19 Société des Produits Nestlé S.A. Controlled-release melatonin compositions and related methods
US10342873B2 (en) 2016-05-06 2019-07-09 Physician's Seal, LLC Valerian composition and related methods
US11141485B2 (en) 2016-05-06 2021-10-12 Société des Produits Nestlé S.A. Valerian composition and related methods
US11141484B2 (en) 2016-05-06 2021-10-12 Société des Produits Nestlé S.A. Valerian composition and related methods
US11701425B2 (en) 2016-05-06 2023-07-18 Société des Produits Nestlé S.A. Valerian composition and related methods
CN110200830B (en) * 2019-05-23 2021-08-03 广州科斯曼生物科技有限公司 Anti-inflammatory and allergy-relieving repair composition and preparation method and application thereof

Also Published As

Publication number Publication date
CA2928777A1 (en) 2014-06-05
WO2014083438A2 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
WO2014083438A3 (en) Nitric oxide increasing nutritional supplements and methods
AU2016202480A1 (en) Seed-origin endophyte populations, compositions, and methods of use
EP3058544A4 (en) Social where next suggestion
EP2986123A4 (en) Improved cognitive supplements
WO2013021279A3 (en) Highly galactosylated antibodies
HK1218549A1 (en) Novel antibody frameworks
EP2989223A4 (en) Copper-nickel-tin alloy with high toughness
PH12015500900B1 (en) A stabilized pemetrexed formulation
EP3052635A4 (en) Alcohol dehydrogenase variants
EP3088700A4 (en) Turbine
WO2014091167A3 (en) Cyclopropylboronic compounds, method for preparing same and use thereof
WO2013123046A3 (en) Cathode buffer materials and related devices and methods
MX362070B (en) Tannin-containing polyols, their production and use.
EP3003328A4 (en) Iron supplement
HK1215429A1 (en) Improved nitric acid oxidation processes
GB2502390B (en) Novel Ni complex and its derivatives, producing method, and the use thereof as antioxidant
EP3018193A4 (en) Microorganism concentrator
EP3231443A4 (en) Statin-encapsulated nanoparticle preparation for enhancing stem cell function, stem cell with enhanced function containing statin-encapsulated nanoparticle, and method for producing same
HK1223300A1 (en) Corticosteroid compositions
EP3038631A4 (en) Anti-inflammatory compositions, methods and uses thereof
EP3003298A4 (en) Anti-fibrogenic compounds, methods and uses thereof
WO2014195861A3 (en) Preparation of ticagrelor
EP3085129A4 (en) Group messaging
EP3078814A4 (en) Turbine
EP3084880A4 (en) Balun

Legal Events

Date Code Title Description
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13859226

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13859226

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2928777

Country of ref document: CA